loader2
Partner With Us NRI

Company details

29.90
29.95
10.15
32.95
6M Return 77.98%
1Y Return 194.58%
Mkt Cap.(Cr) 8.97
Volume 23
Div Yield 0.00%
OI
-
OI Chg %
-
Volume 23

Open Free Demat Account Online with ICICIDIRECT

SWOT

  • swot

  • technicals

  • deals

  • shareholding


EMA SMA

Delivery and volume

Financials

  • Profit and loss statement

  • Balance sheet

  • Quarterly Result

  • Ratio

Sales(Cr.)

Operating Profit(Cr.)

Profit after Tax(Cr.)

Equity

Reserves and Surplus

Debt

Sales

Operating Profit

Profit after tax

PE

Debt/Equity

P BV

INSIDER & INSTITUIONAL ACTIVITY

Equity Capital: 4.03 Cr FV: 10.00
Period MF Net Purchase / (sold) FII Net
LAST 1M 30,916.98 -48,103.23
LAST 3M 78,536.21 -48,038.81
LAST 6M 142,324.16 -197,260.78
LAST 12M 202,697.52 -165,959.31
  • Announcement
  • Corporate action
  • No Data Found

Date Action Type Ratio
No data found

Information

  • About Company
  • Company Info
  • Listing Info
12.67
72.12%
15.5607
-8.82%
-9.44%
Description
  • BNR Udyog Limited is an India-based company. The Company is engaged in carrying on medical transcription, construction and financial activities. The Company is focusing on medical transcription and real estate. The Company is organized in three segments: medical transcription, financial activities/others and National Commodity and Derivatives Exchange (NCDEX). The Company is divided into two geographic segments: the United State and India. BNR Udyog Ltd was incorporated on 29th November 1994, to carry on the business of Stockbroking, Under writing, Merchant Banking and other Financial Activities. The Medical Transcription division of BNR UDYOG LTD was started in August 1999, and is based in Hyderabad, India. It provide high quality medical transcribing services to major health care facilities from a state-of-the-art center. The company`s steadfast clientele includes renowned American hospitals/ polyclinics /MT Companies/ Group of Doctors / Individual Doctors / Respectable persons from medical fraternity. The company`s continuously explore the power of technology to provide solutions that are cost-effective and customer (user)-friendly. It maintains strict adherence to AAMT rules and client Specifications with complete confidentiality of their records. The company has expertise in H&P, SOAP notes, Chart notes, Operative notes, Discharge summaries, Letters etc. of various specialties like Internal medicine, Neurology, Cardiology, Pulmonology, Gastroenterology, Nephrology, Endocrinology, Dermatology, Rheumatology, Allergology, Psychiatry, General Surgery, Neurosurgery, Head & Neck Surgery, Ophthalmology, Otorhinolaryngology, Cardiovascular & Thoracic Surgery, Urology, Orthopedics, Obstetrics & Gynecology, Pediatrics, Neonatology, Pediatric Surgery, Radiology, Pathology, Dentistry, Physical Rehabilitation, Podiatry etc.

Read More

Registered Address

6-3-650 218 2nd Floor, Maheshwari Chambers Somajiguda, Hyderabad, Telangana, 500082

Tel : 91-040-23375791/23375793
Email : info:bnrul.com
Website : http://www.bnrul.com

Registrar

Karvy Computershare Pvt Ltd

AGM Date (Month) : Sep
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 530809
NSE Code :
Book Closure Date (Month) :
BSE Group : X
ISIN : INE355C01016

ICICIdirect BNR Udyog Ltd FAQ

You can buy BNR Udyog Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy BNR Udyog Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of May 17, 2022 04:01 PM the closing price of BNR Udyog Ltd was ₹ 29.90.
Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of May 17, 2022 04:01 PM, the market cap of BNR Udyog Ltd stood at ₹ 8.97.
The latest PE ratio of BNR Udyog Ltd as of May 17, 2022 04:01 PM is 12.67
The latest PB ratio of BNR Udyog Ltd as of May 17, 2022 04:01 PM is 0.52
The 52-week high of BNR Udyog Ltd is ₹ 32.95 while the 52-week low is ₹ 10.15 .

Thank you for subscribing to Equity/ Equity Research/MF/FnO Newsletter. You will hear from us shortly.

for your vote

CLOSE